BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9308943)

  • 1. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Sorosky JI; Magnotta VA; Pelsang RE; Hussey DH
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):395-404. PubMed ID: 9308943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
    Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
    AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix.
    Mayr NA; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Wen BC; Davis CS; Pelsang RE; Anderson B; Doornbos JF; Hussey DH; Yuh WT
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):915-24. PubMed ID: 8751400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
    Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.
    Mayr NA; Yuh WT; Taoka T; Wang JZ; Wu DH; Montebello JF; Meeks SL; Paulino AC; Magnotta VA; Adli M; Sorosky JI; Knopp MV; Buatti JM
    AJR Am J Roentgenol; 2006 Jul; 187(1):65-72. PubMed ID: 16794157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
    Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinical and MRI staging in cervical carcinoma treated with radiation therapy: a single-center experience.
    Engin G; Küçücük S; Ölmez H; Haşıloğlu ZI; Dişçi R; Aslay I
    Diagn Interv Radiol; 2011 Mar; 17(1):44-51. PubMed ID: 20683815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of tumor size on MR imaging in assessing the prognosis of uterine cervical cancer treated with radiation].
    Hayashi T; Kato T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 May; 59(6):250-5. PubMed ID: 10388310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
    Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation.
    Toita T; Kakinohana Y; Shinzato S; Ogawa K; Yoshinaga M; Iraha S; Higashi M; Sakumoto K; Kanazawa K; Sawada S
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):777-82. PubMed ID: 10098432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?
    Baiocchi G; Guimaraes GC; Faloppa CC; Kumagai LY; Oliveira RA; Begnami MD; Soares FA; Lopes A
    Ann Surg Oncol; 2013 May; 20(5):1694-700. PubMed ID: 23212765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
    Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy.
    Narayan K; Fisher R; Bernshaw D
    Int J Gynecol Cancer; 2006; 16(2):623-30. PubMed ID: 16681737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.
    Yamashita Y; Baba T; Baba Y; Nishimura R; Ikeda S; Takahashi M; Ohtake H; Okamura H
    Radiology; 2000 Sep; 216(3):803-9. PubMed ID: 10966715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.